RANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported first quarter 2024 results on ...
Takeda saw a 57% drop in profit in its 2023 fiscal year and has lowered its outlook for the coming fiscal year, mostly driven ...
Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for ...